http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3655892-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6e57c0537fa092c5df8556768afa3b6 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 |
filingDate | 1969-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1972-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e74f9115ffc5d5f0dc662ddbfb5107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edc8d3ca3773ff54797c2093af12c114 |
publicationDate | 1972-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-3655892-A |
titleOfInvention | Pharmaceutical preparations and methods of using same |
abstract | PREPARATIONS CONTAINING 2,4-DIAMINO-6-SUBSTITUTED-S-TRIAZINES AND METHODS OF USING SAME WHEREBY A HOST, INCLUDING MAN, TO WHOM SUCH PREPARATIONS ARE ADMINISTERED, IS PROVIDED WITH ANTI-INFLAMMATORY RELIEF WHILE AVOIDING THE UNWANTED SIDE EFFECTS OF STEROID THERAPY. THE TRIAZINE COMPOUNDS OF THIS INVENTION HAVE THE STRUCTURE 2,4-DI(H2N-),6-R-S-TRIAZINE WHEREIN R IS SELECTED FROM THE GROUP CONSISTING OF PRIMARY ALKYL, SECONDARY ALKYL, TERTIARY ALKYL, SAID ALKYLS HAVING FROM ONE TO 15 CARBON ATOMS, AND R''(CH)N WHEREIN R'' IS SELECTED FROM THE GROUP CONSISTING OF PHENYL, DIPHENYL, CHLOROPHENYL OR METHOXYPHENYL, AND "N" IS A CARDINAL NUMBER HAVING A VALUE OF FROM 1 TO 4. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3966728-A |
priorityDate | 1969-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.